CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 119 filers reported holding CLOVIS ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,776,000 | -61.2% | 1,492,743 | -41.3% | 0.00% | -100.0% |
| Q2 2022 | $4,577,000 | +13.7% | 2,543,088 | +27.7% | 0.00% | – |
| Q1 2022 | $4,024,000 | -70.7% | 1,991,806 | -60.7% | 0.00% | – |
| Q4 2021 | $13,746,000 | +16.9% | 5,071,562 | +92.4% | 0.00% | -100.0% |
| Q3 2021 | $11,758,000 | -24.9% | 2,636,183 | -2.4% | 0.00% | -66.7% |
| Q2 2021 | $15,665,000 | -22.6% | 2,700,886 | -6.4% | 0.00% | 0.0% |
| Q1 2021 | $20,248,000 | -20.5% | 2,884,373 | -45.6% | 0.00% | 0.0% |
| Q4 2020 | $25,462,000 | +94.3% | 5,304,390 | +136.0% | 0.00% | 0.0% |
| Q3 2020 | $13,105,000 | -25.4% | 2,247,775 | -13.7% | 0.00% | -25.0% |
| Q2 2020 | $17,577,000 | -7.6% | 2,604,062 | -13.0% | 0.00% | -33.3% |
| Q1 2020 | $19,031,000 | -51.4% | 2,992,246 | -20.3% | 0.01% | -45.5% |
| Q4 2019 | $39,150,000 | +863.6% | 3,755,335 | +263.2% | 0.01% | +450.0% |
| Q3 2019 | $4,063,000 | -91.0% | 1,033,846 | -66.0% | 0.00% | -60.0% |
| Q2 2019 | $45,186,000 | +49.0% | 3,038,656 | +148.7% | 0.01% | -61.5% |
| Q1 2019 | $30,326,000 | -27.8% | 1,221,846 | -47.8% | 0.01% | -23.5% |
| Q4 2018 | $42,016,000 | +33.3% | 2,339,412 | +118.1% | 0.02% | +70.0% |
| Q3 2018 | $31,510,000 | -60.5% | 1,072,864 | -38.8% | 0.01% | -63.0% |
| Q2 2018 | $79,766,000 | +50.6% | 1,754,257 | +74.9% | 0.03% | +42.1% |
| Q1 2018 | $52,952,000 | -52.8% | 1,002,865 | -39.2% | 0.02% | -52.5% |
| Q4 2017 | $112,212,000 | +49.7% | 1,650,173 | +81.3% | 0.04% | +33.3% |
| Q3 2017 | $74,981,000 | -32.0% | 909,965 | -22.8% | 0.03% | -37.5% |
| Q2 2017 | $110,339,000 | +141.9% | 1,178,457 | +64.5% | 0.05% | +108.7% |
| Q1 2017 | $45,618,000 | +12.0% | 716,472 | -21.9% | 0.02% | +9.5% |
| Q4 2016 | $40,745,000 | -12.7% | 917,278 | -29.2% | 0.02% | -4.5% |
| Q3 2016 | $46,678,000 | +418.1% | 1,294,813 | +97.2% | 0.02% | +450.0% |
| Q2 2016 | $9,009,000 | -57.3% | 656,621 | -40.3% | 0.00% | -63.6% |
| Q1 2016 | $21,115,000 | -34.7% | 1,099,778 | +19.1% | 0.01% | -21.4% |
| Q4 2015 | $32,315,000 | -29.2% | 923,267 | +86.0% | 0.01% | -26.3% |
| Q3 2015 | $45,646,000 | -16.2% | 496,367 | -20.0% | 0.02% | -17.4% |
| Q2 2015 | $54,498,000 | +176.2% | 620,140 | +133.3% | 0.02% | +155.6% |
| Q1 2015 | $19,730,000 | -26.9% | 265,800 | -44.9% | 0.01% | -18.2% |
| Q4 2014 | $26,990,000 | +48.6% | 481,973 | +20.4% | 0.01% | +57.1% |
| Q3 2014 | $18,162,000 | -15.7% | 400,395 | -23.0% | 0.01% | -22.2% |
| Q2 2014 | $21,546,000 | +3.9% | 520,324 | +73.8% | 0.01% | 0.0% |
| Q1 2014 | $20,744,000 | +96.2% | 299,443 | +70.7% | 0.01% | +125.0% |
| Q4 2013 | $10,571,000 | -44.2% | 175,402 | -43.8% | 0.00% | -60.0% |
| Q3 2013 | $18,955,000 | +2496.6% | 311,857 | +2760.8% | 0.01% | – |
| Q2 2013 | $730,000 | – | 10,901 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,997,826 | $10,834,000 | 0.69% |
| Ikarian Capital, LLC | 1,112,669 | $3,016,000 | 0.45% |
| Versant Venture Management, LLC | 101,855 | $276,000 | 0.15% |
| Virtus ETF Advisers LLC | 60,836 | $165,000 | 0.06% |
| EMFO, LLC | 21,500 | $58,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 706,336 | $1,914,000 | 0.03% |
| XTX Topco Ltd | 20,920 | $57,000 | 0.03% |
| State of Wyoming | 25,419 | $69,000 | 0.03% |